Veracyte (VCYT) Current Deferred Tax Assets (2014 - 2015)

Veracyte's (VCYT) quarterly Current Deferred Tax Assets came in at $222000.0 in Q3 2015, down 31.69% year-on-year from $325000.0 in Q3 2014, and down 12.6% quarter-over-quarter from $254000.0 in Q2 2015.

Veracyte (VCYT) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

Veracyte has disclosed Current Deferred Tax Assets across 2 years of filings, most recently posting $222000.0 for Q3 2015.

  • Current Deferred Tax Assets for Q3 2015 came in at $222000.0, down 31.69% year-over-year; the trailing twelve-month figure through Sep 2015 was $222000.0 (down 31.69% YoY), and the FY2014 annual result was $300000.0, changed N/A from the prior year.
  • Current Deferred Tax Assets came in at $222000.0 for Q3 2015 at Veracyte, down from $254000.0 in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $325000.0 in Q3 2014 to a low of $222000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Veracyte 3.91 Bn 3.65 Bn 101.16 Mn

Historic Data

Download Data
DateValue
Sep 30, 2015 222,000.00
Sep 30, 2015 222,000.00
Jun 30, 2015 254,000.00
Jun 30, 2015 254,000.00
Mar 31, 2015 300,000.00
Mar 31, 2015 300,000.00
Dec 31, 2014 300,000.00
Dec 31, 2014 300,000.00
Sep 30, 2014 325,000.00
Sep 30, 2014 325,000.00